India caps trade margins, cutting cancer drug prices up to 96%

From November 9, prices of 137 anti-cancer drugs will fall sharply after the National Pharmaceutical Pricing Authority capped trade margins, with estimated annual consumer savings of Rs 3,502.31 crore. Of 1,225 formulations submitted by 76 companies, 1,031 will see cuts, 600 brands by over 50 per cent and the steepest at 96.45 per cent.